Diagnosis and pharmacological management of Parkinson's disease
This guideline provides recommendations based on current evidence for best practice in the diagnosis and pharmacological management of Parkinson’s disease. It provides recommendations on: the accuracy of diagnoses carried out by different healthcare professionals; the value of different diagnostic tests for differentiating Parkinson’s disease from other associated conditions; and pharmacological management of motor and non-motor symptoms. It also includes a narrative review of qualitative evidence describing the attitudes, beliefs and opinions of patients with Parkinson’s disease.
This guideline will be of interest to general practitioners, neurologists, physicians, geriatricians, nurses, pharmacists, psychologists, psychiatrists, patients, their carers and members of the voluntary sector.